$40.03
-0.92-2.25%
At close: -
$40.54
0.511.28%
After Hours: Nov 8, 5:01 PM EDT
Legend Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Legend Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-0.05 | $-0.38 | 86.8 % |
Mar 2024 | 2024-05-13 | $-0.16 | $-0.34 | 52.9 % |
Dec 2023 | 2024-03-11 | $-0.40 | $-0.83 | 51.8 % |
Sep 2023 | 2023-11-20 | $-0.17 | $-0.65 | 73.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $186.52M | $126.59M | 47.3 % |
Mar 2024 | 2024-05-13 | $93.99M | $152.63M | -38.4 % |
Dec 2023 | 2024-03-11 | $79.46M | $86.35M | -7.97 % |
Sep 2023 | 2023-11-20 | $96.01M | $97.28M | -1.31 % |
Legend Biotech (LEGN) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-0.05, which beat the estimate of $-0.38.
The Actual Revenue was $186.5M, which beat the estimate of $126.6M.
Browse earnings estimates, EPS, and revenue on all stocks.